Literature DB >> 11467843

Structural analyses of the UTF1 gene encoding a transcriptional coactivator expressed in pluripotent embryonic stem cells.

M Nishimoto1, A Fukushima, S Miyagi, Y Suzuki, S Sugano, Y Matsuda, T Hori , M Muramatsu, A Okuda.   

Abstract

The UTF1 is a transcriptional coactivator expressed mainly in pluripotent embryonic stem cells. Here, we have isolated a genomic DNA fragment carrying the UTF1 gene and found that the gene contains two exons interrupted by a short intron. The gene possesses four GC boxes, but no TATA box in the 5'-flanking region. This is reminiscent of a housekeeping gene type promoter and the functional relevance of these motifs is confirmed by the transient transfection analyses. As to the gene product, our analyses have led to the identification of two different species. One of them corresponds to the full-length protein, while the other is produced by utilizing the second methionine codon for the translation initiation. The oligo-capping analyses reveal multiple transcription start sites. Interestingly, some of them are localized downstream of the first methionine codon, indicating that such transcripts produce a protein starting from the second methionine codon. Chromosomal mapping analyses locate the gene at 7F5, the syntenic region of the human chromosome (10q26) where the human UTF1 gene is located. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11467843     DOI: 10.1006/bbrc.2001.5265

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Quantitative proteome analysis of pluripotent cells by iTRAQ mass tagging reveals post-transcriptional regulation of proteins required for ES cell self-renewal.

Authors:  Robert N O'Brien; Zhouxin Shen; Kiyoshi Tachikawa; Pei Angel Lee; Steven P Briggs
Journal:  Mol Cell Proteomics       Date:  2010-05-31       Impact factor: 5.911

2.  Initial colony morphology-based selection for iPS cells derived from adult fibroblasts is substantially improved by temporary UTF1-based selection.

Authors:  Kurt Pfannkuche; Azra Fatima; Manoj K Gupta; Rebecca Dieterich; Jürgen Hescheler
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

3.  Expression pattern of stemness-related genes in human endometrial and endometriotic tissues.

Authors:  Amalia Forte; Maria Teresa Schettino; Mauro Finicelli; Marilena Cipollaro; Nicola Colacurci; Luigi Cobellis; Umberto Galderisi
Journal:  Mol Med       Date:  2009-08-10       Impact factor: 6.354

4.  Myc binds the pluripotency factor Utf1 through the basic-helix-loop-helix leucine zipper domain.

Authors:  Agnieszka I Laskowski; Paul S Knoepfler
Journal:  Biochem Biophys Res Commun       Date:  2013-05-09       Impact factor: 3.575

Review 5.  An Insight into the Role of UTF1 in Development, Stem Cells, and Cancer.

Authors:  Khyati Raina; Chandrima Dey; Madhuri Thool; S Sudhagar; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2021-01-30       Impact factor: 6.692

6.  Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes.

Authors:  Brian Boer; Janel Kopp; Sunil Mallanna; Michelle Desler; Harini Chakravarthy; Phillip J Wilder; Cory Bernadt; Angie Rizzino
Journal:  Nucleic Acids Res       Date:  2007-02-25       Impact factor: 16.971

7.  UTF1 is a chromatin-associated protein involved in ES cell differentiation.

Authors:  Vincent van den Boom; Susanne M Kooistra; Marije Boesjes; Bart Geverts; Adriaan B Houtsmuller; Koshiro Monzen; Issei Komuro; Jeroen Essers; Loes J Drenth-Diephuis; Bart J L Eggen
Journal:  J Cell Biol       Date:  2007-09-04       Impact factor: 10.539

8.  Construction of Discrete Model of Human Pluripotency in Predicting Lineage-Specific Outcomes and Targeted Knockdowns of Essential Genes.

Authors:  Priyanka Narad; Lakshay Anand; Romasha Gupta; Abhishek Sengupta
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.